---
schema_version: "secwatch.filing_event.v1"
accession: "0001728117-26-000022"
form_type: "8-K"
ticker: "GOSS"
cik: "0001728117"
company_name: "Gossamer Bio, Inc."
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:48:03.852224+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Gossamer Bio receives Nasdaq bid price deficiency notice; 180 days to cure

## Summary
- Nasdaq notified Gossamer on April 8, 2026 that stock bid price <$1.00 for 30 consecutive business days (Feb 24 – Apr 7, 2026).
- Company has 180 calendar days, until Oct 5, 2026, to regain compliance by closing bid >=$1.00 for 10 consecutive business days.
- If not cured by Oct 5, may transfer to Nasdaq Capital Market for additional 180-day compliance period if eligible.
- Company will monitor price and consider options including reverse stock split if needed.
- No assurance of regaining compliance; potential delisting.

## SEC filing metadata
- accession: 0001728117-26-000022
- form_type: 8-K
- ticker: GOSS
- cik: 0001728117
- company_name: Gossamer Bio, Inc.
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728117/000172811726000022/0001728117-26-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728117/000172811726000022/goss-20260408.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001728117-26-000022
- JSON: https://secwatch.observer/filing/0001728117-26-000022.json
- Plain text: https://secwatch.observer/filing/0001728117-26-000022.txt

## Source-grounded claims
- claim_id: b6b61931cfa340e565b50602f34e2e7198d04d3c
  claim: Gossamer Bio, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  evidence_excerpt: April 8, 2026, Gossamer Bio, Inc. (the “Company”) received a written notice from the staff (the “Staff”) of the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), notifying the Company that, for the 30 consecutive business day period between February 24, 2026 through April 7, 2026, the Company’s common stock, $0.0001 par value per share (the “Common Stock”), had not maintained a minimum bid price of $1.00 per share, required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). Nasdaq’s w
  evidence_url: https://www.sec.gov/Archives/edgar/data/1728117/000172811726000022/0001728117-26-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.